Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Cheating cell death improves post-infarct heart function

April 23, 2020

Modeling the post-infarct heart

April 22, 2020

Cardurion Pharmaceuticals synthesizes new CAMK2 inhibitors

April 21, 2020

Targeting bystander protein improves sepsis outcome

April 20, 2020

Topoisomerase 2-beta knockdown yields model of diastolic dysfunction

April 15, 2020

Galectin-3 predicts prognosis in sudden cardiac arrest in out-of-hospital patients

April 15, 2020

Exosomes deliver sepsis treatment

April 14, 2020

Cardurion Pharmaceuticals presents CAMK2 inhibitors

April 9, 2020

Novel diet-induced obese rat model of AF

April 6, 2020

Sepsis study may yield new treatment strategies

March 30, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...